nmt 5:    $ 30.00

This tutorial is ideal for all practicing Nuclear Medical Technologists 
seeking 2 hours of CE.

bullet

RADIOPHARMACEUTICAL TUTORIAL This html based tutorial should be accessible to ALL Users

bullet

QUIZ   HTML version


After reviewing this tutorial, participants should be able to discuss the methods of production of isotopes for medical and general commercial use; should be able to define the term "radiopharmaceutical" and to list the properties of the ideal diagnostic and ideal therapeutic radiopharmaceutical; should be able to distinguish between the terms "radiopharmaceutical" and "radiochemical"; should be able to discuss the properties common to all injectable drugs; should be able to state the regulation covering  legal limits for calibrated doses compared to prescribed doses; and should be able to list several examples of dynamic and static studies as well as in vivo non-imaging studies. In addition, they should be able to identify the imaging procedures/target organs associated with every radiopharmaceutical used in the United States, including several INDs; should be able to give the typical administered dose for each of these drugs and the route of administration; should be able to describe the kinetics of most of these drugs, including routes of excretion of the more commonly used radiopharmaceuticals; should be able to describe the stannous reduction method; should be able to describe a hexacoordinated Tc complex and draw its octahedral structure; and should be able to identify special patient preparations and restrictions used for several commonly used radiopharmaceuticals. Finally, they should be able to list and give examples of the 6 classical mechanisms of localization of radiopharmaceuticals as well as some of the mechanisms associated with the newer radiopharmaceuticals; should be familiar with uptake ratios and excretion rates, e.g., the percentage of each of the 5 renal imaging agents cleared by filtration and secretion as well as the amount bound to the tubules; should be able to describe an antigen-antibody reaction and the part it plays in the uptake of radiolabeled monoclonal antibodies by specific types of malignant tumors; and should be able to state legal particle size requirements for those preparations containing labeled particles.

~ Online Catalog ~ HomePage ~ Tutorial Homepage  ~ Email ~

 

Courses Offered By This Website Are Not Affiliated With or Sponsored by 
Loyola University Medical Center.

Home | NucMedTutorials
Any Questions?? Contact Information
This website is owned and operated by nucmedconsultants@comcast.net
copyright ©2008, Consultants in Nuclear Medicine. All Rights Reserved
2910 W. Estes Chicago, Illinois 60645-2934
Phone: 773/802-7617   Fax: 773/304-2545
web design: maxioms.com

Page Last Updated: February 26, 2008